Éva Malpass

66 POSTS 0 COMMENTS

Mapping integrated PFA catheter produces “never before” seen outcomes for the...

This article was sponsored by Biosense Webster “The simplicity, the efficacy and the safety” of pulsed field ablation (PFA) in the treatment of atrial fibrillation...

HRS 2023: Late-breaking clinical trial results support PFA as treatment option...

New data from three late-breaking clinical trials has demonstrated the safety and efficacy of pulsed field ablation (PFA) as a viable, non-thermal treatment option...

Impulse Dynamics announces first implantation of combined CCM and ICD device

impulse dynamics
  Impulse Dynamics has today announced the completion of the first implantation for the INTEGRA-D clinical trial, designed to evaluate the safety and efficacy of...

MicroPort receives FDA approval for latest range of implantable pacemakers

MicroPort
MicroPort, a global developer in the field of cardiac rhythm management, announced today it has received US Food and Drug Administration (FDA) approval for...

Biosense Webster QDot Micro catheter found to improve ablation efficiency for...

Biosense Webster
  Biosense Webster—a stem of Johnson & Johnson MedTech—announced that data from the Q-FFICIENCY study was published in JACC: Clinical Electrophysiology. The study evaluated the...

Artificial intelligence predicts cardiac pump performance

A recent study has found deep neural networks (DDNs)—a category of artificial intelligence (AI) algorithm—capable of forecasting cardiac pump function from standard angiography videos,...

Biotronik receives CE mark for Amvia Sky and Edge devices

Biotronik
Biotronik announced today the latest addition to its cardiac rhythm management portfolio. "We are excited to have received CE mark for our newest technology—the world’s...

CathVision announces first patient enroled in persistent AF study

cathvision
CathVision, a medical technology company developing innovative electrophysiology solutions to enhance clinical decision-making in the electrophysiology (EP) lab, today announced initial patient enrolment of...

Study results demonstrate high detection accuracy for atrial fibrillation using single-lead...

ICD
Results from the MATRIX study show that the high detection accuracy of DX single-lead implantable cardioverter defibrillator (ICD) systems for atrial fibrillation (AF) episodes...

Talking therapy associated with reduced risk of cardiovascular disease

cardiovascular disease talking therapy
Effective management of depression through psychological therapy is associated with a lower likelihood of heart disease and stroke, according to research published today in...

Medtronic mapping and ablation system shows “safety and performance” in treating...

medtronic
Medtronic have announced the 12-month findings that supported the Affera Mapping and Ablation system CE Mark, demonstrating that the Sphere-9 catheter can successfully treat...

EHRA 2023: Severe COVID-19 associated with life-threatening arrhythmia onset within six...

arrhythmia
Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia within six months compared to their peers without...

EHRA 2023: Novel score predicts heart failure following atrial fibrillation ablation

atrial fibrillation ablation
A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation (AF) ablation, according...

EHRA 2023: Novel ablation strategy increases freedom from arrhythmia in AF...

ablation
An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves freedom from arrhythmias in patients with persistent atrial fibrillation (AF)...

EHRA 2023: AF patients have an average of five co-existing medical...

A novel software tool set to improve the management of elderly atrial fibrillation (AF) patients with multiple conditions is being designed by the EU-funded...

EHRA 2023: Electric vehicle chargers found to be safe for patients...

pacemaker
High power electric vehicle chargers are safe for patients with pacemakers and defibrillators, according to a study published in EP Europace, a journal of...

EHRA 2023: Footballer Iker Casillas receives Gold Medal award

Spanish footballer, Iker Casillas, was awarded an European Heart Rhythm Association (EHRA) Gold Medal for services to cardiovascular health yesterday at the 2023 annual...

EHRA 2023: Extended ECG monitoring detects more arrhythmias in hypertrophic cardiomyopathy

hypertrophic cardiomyopathy
Thirty-day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking...

EHRA 2023: Statin use associated with lower risk of stroke in...

statins
A region-wide study in more than 50,000 patients with atrial fibrillation (AF) has found reduced risks of stroke and transient ischaemic attack in those...

Atrial fibrillation risk linked to excessive daytime napping

Daytime napping for 30 minutes or longer is associated with an increased likelihood of developing atrial fibrillation (AF), according to research presented at European...

Wireless pacemakers seen as potentially safe and effective in children with...

pacemakers
Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new...

Smart watches could predict higher risk of heart failure and arrhythmia

Wearable devices such as smart watches could be used to detect a higher risk of developing heart failure and irregular heart rhythms in later...

Women more likely to experience long-term anxiety after cardiac arrest

cardiac arrest
More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men, according to research presented at the...

Health benefits of early rhythm control come with “reasonable” costs for...

atrial fibrillation
Patients with atrial fibrillation (AF) have been said to benefit from early rhythm control therapy, which reduces cardiovascular deaths, strokes, and other adverse outcomes...

Aortix pMCS pump provides “rapid” decongestion for patients with heart failure...

aortix
  Procyrion, a medical device company which aims to improve outcomes for patients with cardiac and renal impairment, announced today that use of its Aortix...

Remote monitoring improves survival in heart failure patients analysis finds

  Abbott has today announced new data that found monitoring patients remotely with haemodynamic pressure sensing technology, such as with its CardioMEMS HF System, can...

HeartBeam accquires LIVMOR assets

heartbeam
HeartBeam, a cardiac technology company that has developed the three-dimensional (3D)-vector electrocardiogram (VECG) platform for heart attack detection today announced the strategic acquisition of...

First patients treated in Kardium PULSAR IDE study of Globe pulsed...

Kardium Globe PFA
Kardium, a private medical device company that has developed the Globe pulsed field (PF) system for the treatment of atrial fibrillation (AF) using pulsed...

Acesion announces positive phase two data from AF clinical trial

AF
Acesion, the biotech developing first-in-class novel therapies for atrial fibrillation (AF), has today announced positive data from its phase two trial of AP30663, a...

Medtronic receives CE Mark approval for Affera mapping and ablation system...

medtronic
Medtronic has announced today that it has received CE Mark for the Affera mapping and ablation system, which includes the Sphere-9 catheter and the...

Low BMI associated with cardiac tamponade during catheter ablation for atrial...

cardiac tamponade
A recent analysis of a large nationwide database of patients with atrial fibrillation (AF) who underwent ablation has reported an independent association between being...

Black, low-income, pregnant women more likely to experience cardiac arrest when...

cardiac arrest pregnancy
A retrospective cohort study investigating the rate of maternal characteristics associated with, and survival following, cardiac arrest during delivery hospitalisation, has found that older,...

Analysis of NIS database shows racial disparities in atrial fibrillation outcomes...

atrial fibrillation
Using data from a large and “nationally representative” sample of the US population, a recent study is the first—the authors posit—to demonstrate racial differences...

Systemic delivery of extracellular vesicles reduces AF in heart failure with...

AF
A recent study has provided new mechanistic insights identifying distinct atrial electrophysiological remodelling and fibrosis-associated conduction abnormalities favouring atrial fibrillation (AF) susceptibility in heart...

Clinical trial set to use biometrics data platform to study hypertrophic...

hypertrophic cardiomyopathy
UC San Francisco (UCSF) is conducting a six-month clinical trial on hypertrophic cardiomyopathy (HCM) using Vivalink's Biometrics Data Platform. The study, consisting of 70...

Early rhythm control aids recurrent stroke prevention in patients with AF

early rhythm control
Early rhythm control one year after atrial fibrillation (AF) diagnosis has been found to be beneficial in preventing recurrent stroke in patients with incident...

Researchers 3D-print hydrodynamic model of aortic stenosis and ventricular remodelling

3D
  Massachusetts Institute of Technology engineers have created a soft robotics-enabled three-dimensional (3D)-printed anatomical hydrodynamic system that can recreate the hemodynamic system of aortic stenosis...

Analysis finds clinical trials frequently overlook people with disabilities

Disabilities were underreported in clinical trial data and commonly used as a basis for exclusion from trial participation in an analysis of 80 recent...

Inpatient AF ablation associated with early mortality and post-procedure complications, study...

AF
Atrial fibrillation (AF) ablation carried out in an inpatient setting is associated with higher rates of early mortality and subsequent complications when compared with...

Healthy or hazardous: Study raises “red flag” on wearable smart device...

CIEDs
A new “red flag-raising” study has provided benchmark data on the safety of smart scales, watches and rings with bioimpedance technology for patients with...

Medtronic receives CE mark for EV-ICD device to treat “dangerous” heart...

EV ICD
  Medtronic has received CE mark for the Aurora extravascular implantable cardioverter-defibrillator (EV-ICD) magnetic resonance imaging (MRI) SureScan device and Epsila EV MRI SureScan defibrillation...

“First study” finds six-fold increase in bradyarrhythmia diagnosis using long-term ILR...

bradyarrhythmia
A retrospective analysis of randomised clinical trials has found that one in five patients aged 70 years or older with cardiovascular risk factors are...

Basketballer Kareem Abdul-Jabbar joins campaign to raise awareness of atrial fibrillation

atrial fibrillation
Kareem Abdul-Jabbar is working with Bristol Myers Squibb and Pfizer to raise awareness of atrial fibrillation (AF) and its symptoms as part of the...

Researchers map potential genetic regulators of the heartbeat

heartbeat
  University of Texas (UT) Southwestern Medical Center researchers have mapped gene control elements in specialised cardiac cells responsible for heartbeat regulation. The findings of...

AF Symposium hears late-breaking data from RFA and PFA trials

Biosense Webster has announced an update and late-breaking data from trials across radiofrequency ablation (RFA) and pulsed field ablation (PFA) at the 2023 AF...

Periodontitis linked to increased risk of AF in Japanese study

af
Researchers have found a correlation between periodontitis and fibrosis scarring to an appendage of the heart’s left atrium that can lead to atrial fibrillation...

Findings show implantable cardioverter defibrillators preservation of arrhythmia shock function not...

implantable cardioverter defibrillators
The prospective cohort study of 626 patients with non-magnetic resonance imaging (MRI)-conditional implantable cardioverter defibrillators (ICDs) suggests said ICDs remain suitable to treat detected...

BioVentrix receives FDA expanded access program approval for ischemic heart failure...

BioVentrix, a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated left ventricle and reverse...

Digital cardiovascular care company tenacio launches US OptiCor AF patient management...

AF
tenacio, a company focused on digitising cardiovascular care to improve patient outcomes and reduce healthcare costs, has announced its OptiCor patient management platform is...

Varian receives IDE for RADIATE-VT cardiac radioablation clinical trial

Varian, associated with Siemens Healthineers, announced today that the US Food and Drug Administration (FDA) approved an investigational device exemption (IDE) for the pivotal...

RA Medical Systems finalises merger with Catheter Precision

Ra Medical Systems announces the completion of its previously-announced stock-for-stock merger transaction with Catheter Precision, a company focused on the cardiac electrophysiology market. MedTech veteran...

Biobeat receives FDA clearance for remote stroke volume and cardiac output...

  Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today that its wearable remote patient monitoring devices have...

CardiacSense receives FDA clearance for medical watch

CardiacSense, a digital health company that developed the world's most advanced, medically certified wearable device for monitoring vital signs, announced receipt of US Food...

Systematic review and meta-analysis finds P-wave duration to increase risk of...

In their updated meta-analysis of 4,175 patients, Stergios Intzes together with a team from the Democritus University of Thrace, Alexandroupoli, Greece and the Heart...

HeartBeam granted European patent for signal transformation from VECG to 12-lead...

heartbeam
HeartBeam, a cardiac technology company that has developed a 3D-vector electrocardiogram (ECG) platform for heart attack detection, has announced that a patent that enables...

Cardiac Insight’s Cardea SOLO wearable ECG system selected for Stanford Medicine...

Cardiac Insight, a specialist in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, has announced that researchers at...

Sudden cardiac arrest data collected in ESCAPE-NET project to improve prevention...

Primary care visits rise sharply in the weeks immediately preceding a sudden cardiac arrest, according to results from the ESCAPE-NET project. The project is...

Measurement of left atrial mechanical function found to improve stroke prediction

A cohort study of more than 4,500 persons without a history of atrial fibrillation (AF) or stroke has found that measuring left atrial mechanical...

Field Medical and CardioNXT to collaborate on 3D integrated PFA therapy

  Field Medical and CardioNXT have announced a strategic collaboration to provide the first-of-its-kind focal pulsed field ablation (PFA) therapy integrated with 3D mapping &...

Biotronik announce first patient enrolment for BIO-CONDUCT Solia S pacing lead...

Biotronik announce the first patient enrolment in BIO-CONDUCT, an US Food and Drug Administration (FDA) approved Investigational Device Exemption (IDE) trial examining the use...

New simulations show weak electrical pulses could treat atrial and ventricular...

AF
With numerical simulations, researchers have demonstrated a new way to time weak electrical pulses that can stop certain life-threatening arrhythmias. Publishing their work in...

New clinical project to use AI ECG data analysis to investigate...

Based in the USA, Weill Cornell Medicine has initiated a new clinical project together with the Mwanza International Trials Unit located in the Lake...

Medtronic completes enrolment in pulsed field ablation catheter trial for patients...

medtronic
Medtronic has announced enrolment completion and final treatment in the SPHERE Per-AF, a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) trial....

Study reveals low reconnection rate with large antral lesion at PW...

A first-of-its-kind analysis on electrophysiological findings in patients with recurrent atrial tachyarrhythmia (ATa) following pulmonary vein isolation (PVI) using the novel pentaspline pulsed-field ablation...

“More research needed” before smartwatches are promoted for heart rhythm disorder...

More scientific evaluation is needed to develop and validate consensus recommendations to ensure that benefits will outweigh risks for consumers who use smartwatches in...

Catheter ablation shown to reduce mortality and hospitalisation in patients with...

An analysis of randomised controlled trials (RCTs) has found catheter ablation reduces mortality and heart failure hospitalisations in patients with atrial fibrillation (AF) and...